KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash from Operations (2016 - 2025)

Neogenomics' Cash from Operations history spans 16 years, with the latest figure at 1343000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 86.3% year-over-year to 1343000.0; the TTM value through Dec 2025 reached 5230000.0, down 25.53%, while the annual FY2025 figure was 5230000.0, 25.53% down from the prior year.
  • Cash from Operations reached 1343000.0 in Q4 2025 per NEO's latest filing, down from 8884000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 20330000.0 in Q2 2025 to a low of 29040000.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 4120800.0, with a median of 2616500.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: plummeted 1576.62% in 2021, then skyrocketed 997.42% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 19776000.0 in 2021, then soared by 81.37% to 3685000.0 in 2022, then soared by 582.61% to 17784000.0 in 2023, then crashed by 44.89% to 9800000.0 in 2024, then tumbled by 86.3% to 1343000.0 in 2025.
  • Per Business Quant, the three most recent readings for NEO's Cash from Operations are 1343000.0 (Q4 2025), 8884000.0 (Q3 2025), and 20330000.0 (Q2 2025).